English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/95795
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Citado 47 veces en Web of Knowledge®  |  Pub MebCentral Ver citas en PubMed Central  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar otros formatos: Exportar EndNote (RIS)Exportar EndNote (RIS)Exportar EndNote (RIS)
Título

DNA methylation map of mouse and human brain identifies target genes in Alzheimer's disease

Autor Sánchez-Mut, José V.; Aso, Esther; Panayotis, Nicolás; Lott, Ira; Dierssen, M.; Rábano, Alberto; Urdinguio, Rocío G.; Fernández, Agustín F.; Astudillo, Aurora; Martín-Subero, José Ignacio; Balint, Balazs; Fraga, Mario F.; Gómez, Antonio; Gurnot, Cecile; Roux, Jean- Christophe; Ávila, Jesús; Hensch, Takao K.; Ferrer, Isidro; Esteller, Manel
Palabras clave Alzheimer’s disease
Brain regions
Epigenetics
DNA methylation
Fecha de publicación 2013
EditorOxford University Press
Citación Brain, a journal of neurology 136: 3018- 3027 (2013)
ResumenThe central nervous system has a pattern of gene expression that is closely regulated with respect to functional and anatomical regions. DNA methylation is a major regulator of transcriptional activity, and aberrations in the distribution of this epigenetic mark may be involved in many neurological disorders, such as Alzheimer's disease. Herein, we have analysed 12 distinct mouse brain regions according to their CpG 5'-end gene methylation patterns and observed their unique epigenetic landscapes. The DNA methylomes obtained from the cerebral cortex were used to identify aberrant DNA methylation changes that occurred in two mouse models of Alzheimer's disease. We were able to translate these findings to patients with Alzheimer's disease, identifying DNA methylation-associated silencing of three targets genes: thromboxane A2 receptor (TBXA2R), sorbin and SH3 domain containing 3 (SORBS3) and spectrin beta 4 (SPTBN4). These hypermethylation targets indicate that the cyclic AMP response element-binding protein (CREB) activation pathway and the axon initial segment could contribute to the disease. © 2013 The Author (2013). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved.
URI http://hdl.handle.net/10261/95795
DOI10.1093/brain/awt237
Identificadoresdoi: 10.1093/brain/awt237
issn: 0006-8950
Aparece en las colecciones: (CBM) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 



NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.